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Abstract: This experiment aimed to investigate the effects of the chitosan (CTS) and   
water-soluble chitosan (WSC) microspheres on plasma lipids in male Sprague-Dawley rats 
fed with high-fat diets. CTS microspheres and WSC microspheres were prepared by the 
spray-drying technique. Scanning electron microscopy (SEM) micrographs showed that the 
microspheres were nearly spherical in shape. The mean size of CTS microspheres was  
4.07 μm (varying from 1.50 to 7.21 μm) and of WSC microspheres was 2.00 μm (varying 
from 0.85 to 3.58 μm). The rats were classified into eight groups (n = 8) and were fed with 
high-fat diets for two weeks to establish the hyperlipidemic condition and were then 
treated with CTS microspheres and WSC microspheres, CTS and WSC for four weeks. The 
results showed that CTS and WSC microspheres reduced blood lipids and plasma viscosity 
and increased the serum superoxide dismutase (SOD) levels significantly. This study is the 
first report of the lipid-lowering effects of CTS and WSC microspheres. CTS and WSC 
microspheres were found to be more effective in improving hyperlipidemia in rats than 
common CTS and WSC. 
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1. Introduction 
Chitosan (CTS), a deacetylated product of the polysaccharide chitin, is a natural 
biopolyaminosaccharide obtained from various organisms, including the exoskeleton of crustaceans, 
such as crabs, shrimps, prawns, lobsters and the cell walls of some fungi (Aspergillus, Zygomicetes and 
Mucor) [1]. The biological properties of CTS, including biocompatibility, biodegradability, low 
toxicity, antitumoral and antiviral activity, make it suitable for use in biomedical and pharmaceutical  
formulations [2]. In food and pharmaceutical industries, CTS has been proposed as a useful carrier for 
the delivery of essential oils and bioactive lipophilic nutraceuticals [3,4], as a dietary supplement [5], 
as a carrier for oral peptide and protein drug delivery [6,7] and for the controlled release of drugs [8]. 
In addition, CTS is a polymer containing glucosamine unit that has high positive charge densities in 
acidic solutions. The strong positive charge carried by the CTS makes it easy to bind negatively 
charged substrates, such as lipids and bile acids [9,10]. CTS also interferes with the emulsification of 
neutral lipids by binding them with hydrophobic bonds [11]. Previous studies revealed that the 
consumption of CTS had a beneficial lowering effect on plasma lipids both in animals and   
humans [12,13]. However, the results of some trials indicated that the effect of CTS on lower lipids 
was minimal and unlikely to be of clinical significance [14,15]. While CTS was believed to be of low 
toxicity and safe in the diet, some reports suggested that excessive intake of CTS resulted in side 
effects in most trials, including constipation, nausea, bloating, indigestion and abdominal pain [16]. 
The evidence of in vitro trials indicated that CTS with a smaller particle size had better   
cholesterol-binding capacities [17]. The pharmaceutical industry always attempts to design drugs as 
microspheres to control the release and elevate the bioavailability [18]. Recently, many kinds of 
microspheres have been prepared by the spray-drying method for narrow distribution and high   
yield [19]. Therefore, CTS microspheres have become one possible solution to the problem. 
In this study, CTS microspheres were prepared by the spray-drying method as an alternative of CTS 
due to its grand bioavailability, control release and minimal side effects. In previous studies, the   
water-soluble chitosan (WSC) was more effective at lipid-lowering [20]. WSC is a derivative of 
chitosan and exhibits good solubility in water. Accordingly, it was important to focus the study on the 
hyperlipidemic effects of both CTS and WSC and the effect of CTS and WSC microspheres on plasma 
lipids in rats fed with high-fat diets. 
2. Results and Discussion 
2.1. Morphology of Microspheres 
The scanning electron microscopy (SEM) micrographs of CTS and WSC microspheres are shown 
in Figure 1. All microspheres were found to be nearly spherical in shape, and the external surfaces of 
the WSC microspheres appeared smooth. The particle size distribution (PSD) of CTS and WSC 
microspheres is shown in Figure 2. The mean particle size of CTS and WSC microspheres was   
4.07 μm and 2.00 μm and varied from 1.50 to 7.21 μm and from 0.85 to 3.58 μm, respectively. Int. J. Mol. Sci. 2013, 14 4176 
 
 
Figure 1. Scanning electron microscopy (SEM) microphotographs of (a) chitosan (CTS) 
microspheres and (b) water-soluble chitosan (WSC) microspheres obtained by spray 
drying (magnification 5,000×). 
 
Figure 2. Particle size distribution (PSD) of (a) CTS microspheres and (b) WSC microspheres. 
 
2.2. Effects on Body Weight 
A significantly lower weight gain was observed by feeding the WSC and high dose CTS 
microspheres compared with feeding the placebos (distilled water) and high-fat emulsions (p < 0.05) 
(Figure 3). However, no significant differences in average weight gain were observed among the 
WSC, CTS and high dose of chitosan microsphere fed rat (HCM) groups. Although, weight gain 
tended to decrease in the CTS, low dose of chitosan microsphere fed rat (LCM) and high dose of 
water-soluble chitosan microsphere fed rat (HWM) groups, the differences were not statistically 
significant compared with normal diet fed rat (NF) and high-fat emulsions fed rat (HF) groups.  Int. J. Mol. Sci. 2013, 14 4177 
 
 
Figure 3. Effects of CTS and WSC microspheres on weight gain in rats fed with high-fat 
diets. Results are expressed as the mean ± SE of eight rats. * p  < 0.05, significantly 
different when compared with rats fed with a normal diet; 
† p < 0.05, significantly different 
when compared with rats fed with a high-fat diets. 
 
During the four-week experiment, daily administration of WSC (225 mg/kg/day) and high-dose 
CTS microspheres (450 mg/kg/day) significantly reduced weight gain. The average weight gain 
decreased in the other treatment groups also, but it was insignificant compared with the NF group. 
This indicated that WSC may prevent high-fat diet induced increase of body weight by affecting food 
absorption, and the CTS microspheres prepared with CTS are more effective in decreasing the weight 
gain than CTS. However, WSC microspheres were not shown to be more effective in decreasing 
weight gain compared to the WSC. This indicated that the anti-obesity mechanism of WSC differed 
with that of CTS for different compositions. Thus, WSC and CTS microspheres may reveal an   
anti-obesity action, but further study is needed to clarify this action. 
2.3. Effects on Serum and Liver TC, TG, HDL-C, LDL-C and SOD 
The results of serum total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol 
(HDL-C) and low-density lipoprotein cholesterol (LDL-C) are presented in Figures 4 and 5. It was 
found that feeding of high-fat emulsions resulted in the elevations of serum TC, TG and LDL-C 
significantly compared with the NF group (p < 0.05), suggesting that hyperlipidemic condition was 
produced in the experimental HF group successfully. In the HCM, LCM, HWM and low dose of  
water-soluble chitosan microsphere fed rat (LWM) groups, serum TC was significantly reduced by 
feeding microspheres compared with NF and HF groups (p < 0.05). However, in the CTS and WSC 
groups, serum TC levels were only significantly reduced compared with the HF group (p < 0.05). The 
serum TG levels of rats in the HF group were significantly higher than those of the CTS and WSC 
microspheres-treated groups (p < 0.05). In contrast, the CTS and WSC groups were not significantly 
different compared with the HF group. When compared with the HF groups, a significant decrease of 
serum LDL-C was seen in the six treatment groups (p < 0.05). However, there was no difference in the 
serum HDL-C among all groups. Int. J. Mol. Sci. 2013, 14 4178 
 
 
Figure 4. Effects on serum total cholesterol (TC) and triglycerides (TG) in rats fed with 
high-fat diets. Results are expressed as the mean ± SE of eight rats. * p  < 0.05, 
significantly different when compared with rats fed with a normal diet; 
†  p  < 0.05, 
significantly different when compared with rats fed with a high-fat diet. 
 
Figure 5. Effects on serum high-density lipoprotein cholesterol (HDL-C) and low-density 
lipoprotein cholesterol (LDL-C) in rats fed with high-fat diets. Results are expressed as the 
mean ± SE of eight rats. * p < 0.05, significantly different when compared with rats fed with a 
normal diet; 
† p < 0.05, significantly different when compared with rats fed with a high-fat diet. 
 
Generally, as the weight is fixed, the smaller the particle size, the bigger is the total surface area. 
CTS and WSC microspheres possess very finer particle size, which may facilitate adsorption of lipids 
and bile acids. In clinical experiments, either a high-dose or low-dose of CTS and WSC microspheres 
can decrease the serum TC, TG or LDL-C levels significantly compared with the HF group, whereas 
CTS and WSC can only decrease the TC significantly compared with the HF group. This is consistent 
with the report that CTS with a finer particle size could effectively lower the plasma lipid level in rats 
fed with a high cholesterol diet [21]. In the present experiment, serum TG levels were not significantly Int. J. Mol. Sci. 2013, 14 4179 
 
 
different in the CTS and WSC groups compared with the HF group. Hossain [22] noted that the reason 
might be related to the fact that TG was an electrically neutral lipid molecule and the positive charge 
of CTS could not interact with the neutral TG molecule of the diet and bile acid in the intestine. Serum 
HDL-C levels increased only slightly in the LCM group, and the serum LDL-C levels decreased 
significantly by feeding the CTS, WSC and microspheres compared with the HF group. The low levels 
of HDL-C and the high levels of LDL-C indicated an imbalance between cholesterol transport from 
the liver to the extrahepatic tissues and back to the liver [22]. Therefore, we proposed that the CTS and 
WSC microspheres could decrease serum TC, TG and LDL-C in hyperlipidemic patients and serve as 
a useful dietary supplement for preventing hyperlipidemia. 
The serum superoxide dismutase (SOD) increased significantly only in the HCM and HWM groups 
compared with the NF and HF group (p < 0.05) and only slightly increased in all other groups, except 
the CTS group (Table 1). Serum SOD also increased by feeding high-dose microspheres compared 
with feeding CTS and WSC. However, there was no significant difference in the LCM and LWM groups. 
There was no significant difference in liver TC, TG, HDL-C and LDL-C levels among all groups at 
the end of the experimental period. Liver SOD level increased significantly by feeding the high dose of 
CTS and WSC microspheres (p  < 0.05). Liver SOD showed an increasing trend in the low-dose 
microspheres-treated groups; however, this increase was not significant compared with the CTS and 
WSC groups (Table 1). 
Table 1. Effects on serum and liver superoxide dismutase (SOD) in rats fed high-fat diets. 
Group  Serum SOD (U/mL)  Liver SOD (U/mL) 
NF  83.43 ± 9.78  0.97 ± 0.34 
HF  87.18 ± 14.01  0.92 ± 0.57 
CTS  72.26 ± 6.10 *
,†  1.65 ± 0.48 *
,† 
WSC  92.35 ± 6.32 *  1.26 ± 0.78 *
,† 
HCM  113.37 ± 11.62 *
,†  4.07 ± 0.73 *
,† 
LCM  90.77 ± 8.49 *  2.94 ± 0.21 *
,† 
HWM  99.15 ± 9.66 *
,†  4.98 ± 0.70 *
,† 
LWM  92.76 ± 10.83 *  1.73 ± 0.41 *
,† 
Values are expressed as means ± SE (n = 8). * p < 0.05, significantly different when compared with 
rats fed with a normal diet; 
† p < 0.05, significantly different when compared with rats fed with 
ahigh-fat diet. 
SOD is one of the major free radical-scavenging systems that might play a role in removing 
superoxide radicals. Excessive superoxide radicals may induce lots of senile diseases, such as 
atherosclerosis. Any elevation in the SOD level is accompanied by a decrease in superoxide   
radicals [23,24]. In this experiment, the serum SOD elevated only significantly by feeding high-dose 
CTS and WSC microspheres compared with the NF and HF groups, and CTS and WSC could not 
increase the serum SOD any further. In the six treatment groups, liver SOD levels showed a significant 
increasing trend. When compared to the CTS and WSC groups, significant differences were seen for 
the HCM and HWM groups. This may be because microspheres can penetrate deeply into tissues 
through fine capillaries. Therefore, we could conclude that the CTS and WSC microspheres increased 
serum and liver SOD levels more effectively than CTS and WSC. Int. J. Mol. Sci. 2013, 14 4180 
 
 
2.4. Effects on Plasma Viscosity 
In this experiment, the average plasma viscosity of rats in the HF group increased significantly 
compared with the average level for rats in the NF group (p < 0.05) (Figure 6). In the six treatment 
groups, plasma viscosity showed a significant decrease compared with the HF group (p < 0.05). 
Figure 6. Effects of CTS and WSC microspheres on plasma viscosity in rats fed with  
high-fat diets. Results are expressed as the mean ± SE of eight rats. * p  < 0.05, 
significantly different when compared with rats fed with a normal diet; 
† p < 0.05, 
significantly different when compared with rats fed with a high-fat diet. 
 
Plasma viscosity played an important role in the perfusion of the microvasculature and was a major 
determinant of endothelial shear stress [25]. It was used as a marker for different diseases in humans, 
such as coronary artery disease and atherosclerosis [26]. The rats’ plasma viscosity increased 
significantly by feeding the high-fat emulsions, and CTS and WSC microspheres reduced this increase 
effectively. Furthermore, the microspheres were more effective than CTS and WSC. There was no 
significant difference in plasma viscosity among the microsphere-treated groups, which suggested that 
the rats’ high plasma viscosity model used previously did not adequately simulate the human 
hypocholesterolemia. However, further human studies are needed to confirm this. 
3. Experimental Section 
3.1. Chemicals 
CTS and WSC with an average molecular weight of 350 kD and 200 kD were purchased from 
Shandong Aokang Biotech Ltd. (Shandong, China). The viscosity was more than 200 cps, and 
deacetylation values were 96.2% and 85%, respectively. Total cholesterol (TC), triacylglycerol (TG), 
high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) kits 
were obtained from BioSino Bio-technology and Science Inc. (Beijing, China). Superoxide dismutase 
(SOD) kits were purchased from Nanjing Jiancheng Bioengineering Institute (Wenzhou, China). 
Unless otherwise stated, all laboratory reagents were of analytical grade. Int. J. Mol. Sci. 2013, 14 4181 
 
 
3.2. Animals and High-Fat Emulsions 
Male Sprague-Dawley rats weighing 200 ± 20 g were purchased from Guangzhou University of 
Chinese Medicine Laboratory Animal Center (Guangzhou, China). All animal protocols were 
approved by the Institutional Animal Care and Use Committee of Guangdong Pharmaceutical 
University (Guangzhou, China). They were housed in an isolator caging system in an air-conditioned 
animal room at 23 ± 1 °C and had free access to food and water. The high-fat emulsions were prepared 
by the method of our previous study [27]. 
3.3. Preparation and Characterization of CTS and WSC Microspheres 
CTS and WSC microspheres were prepared by the spray-drying technique. Dissolving CTS in 
acetic acid (1.0% v/v) produced the solution containing 2.5% (w/v) CTS, and the WSC solution was 
prepared by dissolving WSC in deionized water containing 2.0% (w/v) WSC. The solutions were then 
spray dried using the Lab Spray Dryer L-117 (Laiheng Scientific Co. Ltd., Beijing, China) with a 
standard nozzle (0.7 mm). The atomizing air flow rate was 10–15 L/min, and the flow rate was   
600 mL/h. The inlet temperature was controlled at 160 °C. The outlet temperature varied between 80 
and 85 °C and was determined by the inlet temperature and other relative factors, such as air and liquid 
feed flow rates. The morphology of the microparticles was examined under scanning electron 
microscopy (SEM) using a Hitachi S3700N (Hitachi Ltd., Tokyo, Japan) microscope at 10 kV. The 
particle size and size distributions of the CTS microspheres and WSC microspheres were determined 
with a particle sizer (Zetasizer 3000HS Malvern Instruments Ltd., Malven, UK). 
3.4. Experimental Procedure 
The rats were fed ad libitum with a commercial diet for five days and were then classified into eight 
groups (n = 8): normal fat control group (NF), high fat control group (HF), chitosan control group (CTS), 
water-soluble chitosan control group (WSC), chitosan microsphere group (high-dose (HCM) and low-dose 
(LCM)) and water-soluble chitosan microsphere group (high-dose (HWM) and low-dose (LWM)). 
The NF group received an equivalent amount of distilled water; the HF group received high-fat 
emulsions daily by oral intubation until the study ended. The other groups were administered high-fat 
emulsions by oral intubation for two weeks to establish the hyperlipidemic condition, and then, the 
CTS and WSC samples (450 mg/kg/day) were administered orally once per day to the CTS and WSC 
group for four weeks. Similarly, two doses (high dose 450 mg/kg/day; low dose 225 mg/kg/day) of 
CTS and WSC microspheres were administered orally once per day to the HCM, LCM, HWM and 
LWM groups for four weeks after two weeks to establish the hyperlipidemic condition. CTS, WSC, 
CTS microspheres and WSC microspheres (5.0 g) were dissolved with distilled water (100 mL). All 
groups were fed the corresponding diets in which the composition conformed to GB14924.3 
(Guangdong Laboratory Animal Center, Guangzhou, China) as the basal diets during the whole 
experiment. Each rat was weighed once a week. 
At the end of the experimental period, blood samples were withdrawn from the orbital venous 
plexus using a capillary tube under ether anesthesia after an overnight fast. Then, the rats were Int. J. Mol. Sci. 2013, 14 4182 
 
 
decapitated and their livers were quickly removed and weighed. The liver pieces was immediately 
stored at −80 °C until analysis. 
3.5. Serum and Liver Lipids and SOD 
Blood was clotted at room temperature and centrifuged at 3,000 rpm for 15 min. Serum was 
separated and TC, TG, HDL-C and LDL-C levels were measured with commercial assay kits using the 
Automated Biochemistry Analyzer AMS-18 (Beijing Option Science and Technology Development 
Co. Ltd., Beijing, China). 
The liver TG, TC, HDL-C and LDL-C contents were measured as follows: a piece (0.1 g) of liver 
tissue was homogenized with chloroform-methanol (2:1, v/v, 2 mL), and the homogenate was extracted 
with chloroform-methanol (2:1, v/v, 3 mL) by shaking the tubes horizontally for 24 h in a shaker. The 
mixtures were centrifuged at 3,000 rpm for 5 min, and the upper aqueous phase was removed by 
suction. The liver TG, TC, HDL-C and LDL-C contents were analyzed with commercial assay kits. 
The serum and liver SOD contents were analyzed with the commercially available analytical kit by 
the SPECORD S600 UV-Vis Spectrophotometer (Analytic Jena AG, Jena, Germany). 
3.6. Plasma Viscosity 
In order to obtain plasma, blood samples were taken from the ocular vein using a heparinized 
capillary tube and centrifuged at 3,000 rpm for 5 min in the Eppendorf Centrifuge 5810R (Eppendorf Co., 
Hamburg, Germany). The plasma viscosity was measured using the Automatic Blood Rheometer 
LBY-N6B (Beijing Precil Instrument Co. Ltd., Beijng, China). 
3.7. Statistical Analysis 
All data were expressed as the mean ± SE. Differences between the groups were determined by  
one-way analysis of variance (ANOVA) using a statistical analysis software program, SPSS   
(version Rel., 16.0, Spss Inc., Chicago, IL, USA). The Student-Newman-Kuels Multiple Range Test 
comparisons at p value of <0.05 were made to determine significant differences among means. 
4. Conclusions 
To conclude, the results indicated that the microspheres prepared from common CTS and WSC are 
effective in lowering serum lipid levels and plasma viscosity and increasing SOD levels in rats fed 
with high-fat emulsions. Thus, the particle sizes of CTS and WSC affect their hypocholesterolemic 
activities. Further clinical studies are needed to clarify the preventive effect on diet-induced obesity of 
the microspheres. In our previous article, the median lethal dose (LD50) values of CTS, WSC and CTS 
microspheres were >10,000 mg/kg, and the median lethal dose values of WSC microspheres were  
4,080 mg/kg [28]. To date, all rats appear healthy and remain active after oral administration of the 
CTS, WSC and their microspheres. Therefore, CTS, WSC, CTS and WSC microspheres can be 
considered as safe functional polymers. Int. J. Mol. Sci. 2013, 14 4183 
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